Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 10 | 2022 | 935 | 3.510 |
Why?
|
| Genomics | 5 | 2022 | 223 | 2.130 |
Why?
|
| Neoplasms | 6 | 2023 | 1103 | 1.920 |
Why?
|
| Computational Biology | 5 | 2016 | 293 | 1.550 |
Why?
|
| Mutation | 6 | 2022 | 1095 | 1.510 |
Why?
|
| Prostate-Specific Antigen | 2 | 2021 | 118 | 1.490 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2020 | 807 | 1.170 |
Why?
|
| Gene Regulatory Networks | 4 | 2022 | 120 | 1.110 |
Why?
|
| RNA, Messenger | 4 | 2016 | 1207 | 1.090 |
Why?
|
| Gene Expression Profiling | 5 | 2020 | 626 | 1.040 |
Why?
|
| Genes, Neoplasm | 2 | 2018 | 13 | 1.040 |
Why?
|
| MicroRNAs | 3 | 2016 | 426 | 0.930 |
Why?
|
| Genome-Wide Association Study | 2 | 2022 | 333 | 0.890 |
Why?
|
| SEER Program | 2 | 2020 | 91 | 0.860 |
Why?
|
| Lymphocytes | 2 | 2013 | 118 | 0.830 |
Why?
|
| Ovarian Neoplasms | 2 | 2016 | 312 | 0.800 |
Why?
|
| Prognosis | 6 | 2022 | 739 | 0.800 |
Why?
|
| Mibefradil | 1 | 2021 | 2 | 0.790 |
Why?
|
| Calcium Channels, T-Type | 1 | 2021 | 3 | 0.790 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2021 | 767 | 0.780 |
Why?
|
| Cyclopropanes | 1 | 2021 | 40 | 0.780 |
Why?
|
| Naphthalenes | 1 | 2021 | 38 | 0.780 |
Why?
|
| Benzimidazoles | 1 | 2021 | 36 | 0.770 |
Why?
|
| Calcium Channel Blockers | 1 | 2021 | 56 | 0.770 |
Why?
|
| Humans | 27 | 2023 | 37093 | 0.750 |
Why?
|
| DNA Mutational Analysis | 2 | 2018 | 93 | 0.730 |
Why?
|
| Models, Genetic | 2 | 2018 | 172 | 0.730 |
Why?
|
| Alu Elements | 2 | 2011 | 10 | 0.730 |
Why?
|
| Cluster Analysis | 5 | 2020 | 195 | 0.700 |
Why?
|
| Herpesvirus 4, Human | 2 | 2016 | 33 | 0.690 |
Why?
|
| Tobacco Use Disorder | 1 | 2023 | 237 | 0.680 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2022 | 213 | 0.650 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 63 | 0.640 |
Why?
|
| Gene Silencing | 1 | 2018 | 151 | 0.610 |
Why?
|
| Models, Molecular | 1 | 2021 | 808 | 0.600 |
Why?
|
| Genome, Human | 3 | 2014 | 135 | 0.590 |
Why?
|
| Software | 1 | 2018 | 217 | 0.560 |
Why?
|
| Databases, Nucleic Acid | 1 | 2016 | 27 | 0.560 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2016 | 15 | 0.560 |
Why?
|
| Smoking Cessation | 1 | 2023 | 517 | 0.560 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 251 | 0.550 |
Why?
|
| Sequence Analysis, RNA | 2 | 2013 | 106 | 0.550 |
Why?
|
| Exons | 2 | 2013 | 88 | 0.550 |
Why?
|
| Models, Statistical | 2 | 2014 | 180 | 0.540 |
Why?
|
| Public Health | 1 | 2020 | 372 | 0.540 |
Why?
|
| Head and Neck Neoplasms | 1 | 2016 | 78 | 0.520 |
Why?
|
| DNA Methylation | 1 | 2018 | 325 | 0.510 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 178 | 0.480 |
Why?
|
| Computer Simulation | 1 | 2016 | 362 | 0.470 |
Why?
|
| Carcinoma | 1 | 2014 | 96 | 0.470 |
Why?
|
| Proteins | 1 | 2016 | 369 | 0.460 |
Why?
|
| DNA Transposable Elements | 1 | 2013 | 48 | 0.450 |
Why?
|
| Signal Transduction | 4 | 2016 | 1908 | 0.450 |
Why?
|
| Male | 10 | 2022 | 20025 | 0.440 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 213 | 0.430 |
Why?
|
| Survival Analysis | 3 | 2020 | 325 | 0.430 |
Why?
|
| Carrier Proteins | 1 | 2014 | 305 | 0.420 |
Why?
|
| Papillomavirus Infections | 1 | 2016 | 336 | 0.400 |
Why?
|
| Aged | 4 | 2023 | 6741 | 0.350 |
Why?
|
| Algorithms | 4 | 2016 | 465 | 0.340 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 1015 | 0.280 |
Why?
|
| Incidence | 2 | 2020 | 922 | 0.270 |
Why?
|
| Aged, 80 and over | 2 | 2023 | 2379 | 0.260 |
Why?
|
| Regression Analysis | 2 | 2020 | 455 | 0.250 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 628 | 0.230 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 1502 | 0.230 |
Why?
|
| Lysine | 1 | 2023 | 113 | 0.220 |
Why?
|
| Middle Aged | 3 | 2023 | 10129 | 0.220 |
Why?
|
| Linear Models | 2 | 2013 | 275 | 0.210 |
Why?
|
| Neutrophils | 1 | 2023 | 131 | 0.210 |
Why?
|
| Bayes Theorem | 1 | 2022 | 94 | 0.200 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 128 | 0.190 |
Why?
|
| Cell Line | 3 | 2015 | 1354 | 0.190 |
Why?
|
| ROC Curve | 1 | 2021 | 138 | 0.190 |
Why?
|
| Transcription, Genetic | 2 | 2015 | 578 | 0.190 |
Why?
|
| Germ Cells | 1 | 2021 | 73 | 0.190 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 242 | 0.180 |
Why?
|
| Databases, Genetic | 1 | 2020 | 93 | 0.180 |
Why?
|
| Prostatectomy | 1 | 2020 | 63 | 0.180 |
Why?
|
| Demography | 1 | 2020 | 175 | 0.170 |
Why?
|
| CpG Islands | 1 | 2018 | 97 | 0.160 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 974 | 0.160 |
Why?
|
| Registries | 1 | 2020 | 335 | 0.160 |
Why?
|
| Risk Assessment | 1 | 2021 | 753 | 0.160 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1130 | 0.150 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 114 | 0.150 |
Why?
|
| Age Factors | 1 | 2020 | 1033 | 0.140 |
Why?
|
| Interleukins | 1 | 2016 | 29 | 0.140 |
Why?
|
| Databases, Protein | 1 | 2016 | 48 | 0.140 |
Why?
|
| Prevalence | 1 | 2021 | 1455 | 0.140 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2016 | 61 | 0.140 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2016 | 9 | 0.140 |
Why?
|
| Hyperinsulinism | 1 | 2016 | 17 | 0.140 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2016 | 32 | 0.140 |
Why?
|
| Smoking | 1 | 2023 | 940 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 515 | 0.140 |
Why?
|
| Interleukin-17 | 1 | 2016 | 53 | 0.130 |
Why?
|
| Receptors, Androgen | 1 | 2016 | 126 | 0.130 |
Why?
|
| Octamer Transcription Factors | 1 | 2015 | 1 | 0.130 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2015 | 4 | 0.130 |
Why?
|
| RNA, Untranslated | 1 | 2015 | 42 | 0.130 |
Why?
|
| Atlases as Topic | 1 | 2014 | 5 | 0.130 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2015 | 110 | 0.120 |
Why?
|
| Expressed Sequence Tags | 1 | 2013 | 27 | 0.120 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 2721 | 0.120 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 146 | 0.120 |
Why?
|
| Logistic Models | 1 | 2016 | 923 | 0.110 |
Why?
|
| Quantitative Trait Loci | 1 | 2013 | 77 | 0.110 |
Why?
|
| Virus Replication | 1 | 2015 | 278 | 0.110 |
Why?
|
| Young Adult | 1 | 2023 | 4268 | 0.110 |
Why?
|
| Linkage Disequilibrium | 1 | 2012 | 85 | 0.100 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 74 | 0.100 |
Why?
|
| Genes, Recessive | 1 | 2011 | 7 | 0.100 |
Why?
|
| Inflammation | 1 | 2016 | 618 | 0.100 |
Why?
|
| Introns | 1 | 2011 | 75 | 0.100 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 219 | 0.100 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 197 | 0.090 |
Why?
|
| Gene Expression | 1 | 2013 | 674 | 0.090 |
Why?
|
| Organ Specificity | 1 | 2010 | 129 | 0.090 |
Why?
|
| Binding Sites | 1 | 2012 | 651 | 0.090 |
Why?
|
| Genotype | 1 | 2012 | 730 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 306 | 0.080 |
Why?
|
| Pan troglodytes | 1 | 2009 | 21 | 0.080 |
Why?
|
| Data Mining | 1 | 2009 | 23 | 0.080 |
Why?
|
| Drosophila melanogaster | 1 | 2010 | 180 | 0.080 |
Why?
|
| Sequence Alignment | 1 | 2009 | 265 | 0.080 |
Why?
|
| Obesity | 1 | 2016 | 1067 | 0.080 |
Why?
|
| Female | 3 | 2016 | 20969 | 0.080 |
Why?
|
| Adult | 1 | 2023 | 11712 | 0.070 |
Why?
|
| Animals | 3 | 2016 | 15081 | 0.060 |
Why?
|
| Acetylation | 1 | 2023 | 98 | 0.060 |
Why?
|
| Catalytic Domain | 1 | 2023 | 109 | 0.060 |
Why?
|
| Catalysis | 1 | 2023 | 179 | 0.060 |
Why?
|
| Mice, Obese | 1 | 2016 | 40 | 0.030 |
Why?
|
| Replication Origin | 1 | 2015 | 14 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 123 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2015 | 149 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2015 | 186 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2016 | 928 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2016 | 1518 | 0.030 |
Why?
|
| Protein Binding | 1 | 2015 | 972 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 539 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1198 | 0.020 |
Why?
|
| Apoptosis | 1 | 2016 | 1398 | 0.020 |
Why?
|
| Mice | 1 | 2016 | 5913 | 0.020 |
Why?
|